- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05469269
Cleveland African American Prostate Cancer Project
April 3, 2026 updated by: Case Comprehensive Cancer Center
Cleveland African American Prostate Cancer Project: Equivalence of Passive Navigation, Active Navigation, and Community-based Screening for Completion of Prostate Cancer Screening
The purpose of this research is to test intervention strategies that encourage and support Black or African American men who are 40 and older to complete prostate cancer screening, and specifically to complete a prostate-specific antigen (PSA) test.
Study Overview
Status
Recruiting
Conditions
Detailed Description
This intervention is designed to evaluate the effectiveness of three different approaches to increasing PSA screening in African American men, starting at age 40.
The approaches are 1) education and passive navigation, 2) education and active navigation, and 3) education and active navigation with community based outreach.
Completion of a PSA blood test is the primary outcome of this study, which will be evaluated four months following the recruitment phase at each shop.
At the 4 month follow-up, participants will be asked about PSA completion; participants who completed PSA screening will be asked to provide outcomes from their PSA screening (ie.
PSA results and provider recommended next steps), as well as their feelings regarding their screening experience, trust in the screening process, and knowledge about prostate cancer.
Study Type
Interventional
Enrollment (Estimated)
800
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Erika Trapl, PhD
- Phone Number: 216-368-8772
- Email: CAAPP@case.edu
Study Locations
-
-
Ohio
-
Cleveland, Ohio, United States, 44106
- Recruiting
- Barbershops Local to Cleveland
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
40 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- ≥40 years old
- Self-identify as Black or African American
- Have a prostate gland (includes biological males, transwomen)
- PSA-naïve or has not received a PSA test in the past 12 months
- Has not had a previous prostate cancer diagnosis
- English speaking
- Ability to consent to study
Exclusion Criteria:
- Individuals who have had a prostatectomy
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Screening
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Education and Passive Navigation
This arm receives barber-led education and access to a resource website.
Barbers will encourage clients to access the screening website.
Other study materials will also be located within the shop.
The resource website will be accessible via QR code that will encourage potential participants to complete a Prostate Cancer Knowledge and Risk Assessment questionnaire.
|
Education: QR codes will be posted at each barber's station within a barber shop, as well as on other study materials located within the shop.
The QR code recruitment mechanism will encourage potential participants to complete a Prostate Cancer Knowledge and Risk Assessment questionnaire (ie.
Screener) which acts as a screener for study eligibility.
The screener can be completed by scanning the QR code with a cell phone while in the barbershop.
Barbers will encourage their clients to complete the Screener.
|
|
Experimental: Education and Active Navigation
This arm includes all interventions of the first arm plus the addition of a community navigator.
The community navigator will be onsite to assist in information delivery and navigation to resources and encourage the completion of the Screener through the QR code.
The community navigator will help participants connect with a primary care provider to continue with all preventive healthcare recommendations.
|
Education: QR codes will be posted at each barber's station within a barber shop, as well as on other study materials located within the shop.
The QR code recruitment mechanism will encourage potential participants to complete a Prostate Cancer Knowledge and Risk Assessment questionnaire (ie.
Screener) which acts as a screener for study eligibility.
The screener can be completed by scanning the QR code with a cell phone while in the barbershop.
Barbers will encourage their clients to complete the Screener.
A community navigator will be onsite to assist in information delivery, navigation to resources, and encourage the completion of the Screener through the QR code.
Participants can opt to connect with the community navigator if they have questions, need assistance in scheduling a PSA screening, or if they have other resource needs.
The community navigator will help participants connect with a primary care provider to continue with all preventive healthcare recommendations.
|
|
Experimental: Education and Active Navigation with Community Based Outreach
This arm adds the community navigator and a community outreach screening event.
Case Comprehensive Cancer Center Community Outreach and Engagement will offer barber shops an onsite PSA screening event.
|
Education: QR codes will be posted at each barber's station within a barber shop, as well as on other study materials located within the shop.
The QR code recruitment mechanism will encourage potential participants to complete a Prostate Cancer Knowledge and Risk Assessment questionnaire (ie.
Screener) which acts as a screener for study eligibility.
The screener can be completed by scanning the QR code with a cell phone while in the barbershop.
Barbers will encourage their clients to complete the Screener.
A community navigator will be onsite to assist in information delivery, navigation to resources, and encourage the completion of the Screener through the QR code.
Participants can opt to connect with the community navigator if they have questions, need assistance in scheduling a PSA screening, or if they have other resource needs.
The community navigator will help participants connect with a primary care provider to continue with all preventive healthcare recommendations.
The Community Navigator will set up PSA screening events at specific barber shops for participants who wish to move forward with screenings.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
PSA Screening Test
Time Frame: At 4 months
|
The number of participants who had a PSA screening test completed.
|
At 4 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
PSA Screening Test
Time Frame: At 14 months
|
The number of participants who had a PSA screening test completed.
|
At 14 months
|
|
Primary Care Physician Visit
Time Frame: At 4 months
|
The number of participants that followed up with a primary care physician for a visit or to establish long-term routine care.
|
At 4 months
|
|
Primary Care Physician Visit
Time Frame: At 14 months
|
The number of participants that followed up with a primary care physician for a visit or to establish long-term routine care.
|
At 14 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Erika Trapl, PhD, Case Comprehensive Cancer Center
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 9, 2023
Primary Completion (Estimated)
October 28, 2026
Study Completion (Estimated)
September 30, 2027
Study Registration Dates
First Submitted
July 19, 2022
First Submitted That Met QC Criteria
July 19, 2022
First Posted (Actual)
July 21, 2022
Study Record Updates
Last Update Posted (Actual)
April 8, 2026
Last Update Submitted That Met QC Criteria
April 3, 2026
Last Verified
April 1, 2026
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CASE7822
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
IPD Plan Description
All IPD that underlies results in publication.
IPD Sharing Time Frame
Available immediately after publication with no end date.
IPD Sharing Access Criteria
Researchers who provide a sound proposal.
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.